Grant funding can be a catalyst for scientific and commercial progress. Adriann Sax, CEO & Co-Founder of Vetigenics, shares how strategic use of SBIR and foundation grants enabled the company to build a canine antibody platform, attract support from investors, and secure partners such as Merck Animal Health.
Speaker(s):
Adriann Sax
President & CEO
Vetigenics
Time:
10.30am - 10.50am
Agenda Track No.:
Track 3
Summary:
Session Will be Recorded - Attend live or Watch On-Demand
Session Type:
General Session (Presentation)
Force Inline Description:
0